Company news

Memphasys Ltd news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

First Felix System commercial sale for clinical IVF use

December 20, 2021

First Sale of FelixTM in Research Application

November 21, 2021

Verification and Validation Assessments Complete

November 2, 2021

MEM: Reaches settlement agreement with Hydrix

August 31, 2021

Memphasys completes $3m capital raise

May 26, 2021

Quarterly Cashflow Report

April 30, 2021

Quarterly Activities Report

April 29, 2021

Initial Felix product sales update

December 24, 2020

FELIX verification and validation update

November 18, 2020

Response to ASX Price Query

October 7, 2019

MEM appoints FELIX manufacturer and raises new capital

July 9, 2019

Cleansing Prospectus

June 5, 2019

Rights Issue Prospectus shortfall

March 26, 2019

Rights Issue Prospectus

February 28, 2019

Entitlement issue and dual listing

February 26, 2019

Response to ASX aware query

October 23, 2018

Response to ASX price query

October 18, 2018

Pause in trading

October 17, 2018

Collaborative Agreement with Monash IVF Group

September 18, 2018

Proposed share consolidaiton

July 3, 2018

Memphasys raises $1m via a strategic investment

May 25, 2018

Felix device development update

May 2, 2018

Appendix 4D - December 2017 Half year Financial Accounts

February 23, 2018

Legal action with Platinum Road / Bridge Road Capital

February 12, 2018

$400,000 Special Grant received from the NSW Medical Devices

December 21, 2017

MEM Non-Renounceable Rights Issue Offer

November 27, 2017

$400,000 special grant offer from NSW Medical Devices Fund

November 24, 2017

$3.75M Capital Raising to Accelerate Dev of Felix Device

November 21, 2017

Advanced development of Felix device supported by R&D rebate

October 10, 2017

Adjusting amendment to Appendix 4E

September 13, 2017

Appendix 4E Preliminary Final Report

August 31, 2017

Correction to Outcome of Litigation

July 27, 2017

Outcome of Litigation

July 26, 2017

Felix Project development update

July 13, 2017

Extension of Director line of credit

July 3, 2017

SpermSep device development update

June 29, 2017

Update on SpermSep Device Development

May 17, 2017

Completes sale of Gels business and Crescendas Loan clarific

April 5, 2017

Commence next phase of SpermSep Development and new funding

April 4, 2017

Loan from Crescendas Projects and PrIME legal dispute update

March 2, 2017

Appendix 4D and Half Year Financial Accounts

February 28, 2017

Funding Update - loan and line of credit

February 23, 2017

Update on Dispute Resolution Process

February 16, 2017

Statutory Demand To Be Set Aside

February 14, 2017

Memphasys Capital Raising Review

December 16, 2016

Capital Raising

December 12, 2016

Statement of claim from transocean securities

November 21, 2016

Update on litigation against prime

November 11, 2016

Capital Raising and New Corporate Advisor

September 20, 2016

Letter of Demand from PrIME and Manukan re A-Bio Debt Repaym

September 12, 2016

← Newer news releases · Older news releases →

Decks

The 5 newest of 20 decks. Every deck is listed under its year.